Skip to main content
. 2021 Dec 30;100(52):e28458. doi: 10.1097/MD.0000000000028458

Table 4.

Impact of the intervention on intradermal skin test, prophylactic antibiotics, and drug costs.

Effect size (95% confidence intervals) P
Patients with intradermal skin tests, OR 0.008 (0.005, 0.014) <.001
Cephalosporin as POABP, OR 5.28 (2.95, 9.43) <.001
Cost
 Total drugs per patient ($), Coef –7.34 (–165.61, 150.93) .928
 Antibiotics cost per patient ($), Coef –150.21 (–225.00, –75.43) <.001
 Antibiotics cost percentage, Coef –3.2% (–4.7%, –1.7%) <.001